Autres langues Bio-Techne Corporation

Actions

TECH

US09073M1045

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/06/2026			Varia. 5j.	Varia. 1 janv.
55,00 ^USD	-1,84 %		+1,08 %	-6,48 %

15/06	Bio-Techne sous la pression d'Ananym Capital pour envisager une vente	MT
11/06	BIO-TECHNE CORPORATION : Piper Sandler n'est plus acheteur	ZM

Autres langues

15/06	Bio-Techne Faces Pressure From Ananym Capital to Explore Sale
05/06	Bio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
04/06	Bio-Techne Corporation and Refeyn Announces Integrated Workflow for Bispecific Antibody and Biosimilar Characterization
04/06	Bio-Techne, Refeyn Introduce Antibody Testing Workflow
04/06	Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
15/05	Bio-Techne's Planned Wilson Wolf Acquisition Underappreciated by Investors, RBC Says
12/05	Bio-Techne Insider Sold Shares Worth $320,386, According to a Recent SEC Filing
08/05	Analyst recommendations: Airbnb , Citigroup , The Walt Disney Company , Block, Cloudflare...
06/05	Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026
06/05	Bio-Techne's Fiscal Q3 Adjusted Earnings, Revenue Fall
06/05	Bio-Techne misses revenue estimates as US academic funding cuts dent demand
06/05	Earnings Flash (TECH) Bio-Techne Corporation Reports Q3 Revenue $311.4M, vs. FactSet Est of $316.1M
06/05	Earnings Flash (TECH) Bio-Techne Corporation Posts Q3 Adjusted EPS $0.53 per Share, vs. FactSet Est of $0.53
06/05	Bio-Techne Declares Dividend
06/05	Bio-Techne Releases Third Quarter Fiscal 2026 Results
06/05	Bio-Techne Corporation announces Quarterly dividend, payable on May 29, 2026
04/05	Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
28/04	Cleo Diagnostics Starts Manufacturing, Development Program for Ovarian Cancer Test Kit Production; Shares Up 8%
16/04	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16/04	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16/04	Bio-Techne Corporation Introduces Streamlined Brand Architecture With Three Portfolio Brands
14/04	Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
26/03	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite
25/03	Bio-Techne Corporation Expands Comet Solution Portfolio with Addition of Spyre Focus Panels and Spyre Amplification Kits
25/03	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite